Nova News
WILLIAM & MARY | RAYMOND A. MASON SCHOOL OF BUSINESS EMBA COHORT VISITS EYRIS
7 May 2024 – EyRIS had a great day hosting an EMBA delegation from William & Mary | Raymond A. Mason School of Business, a distinguished public research university and the 2nd oldest institution of higher learning located in Williamsburg, Virginia. WM’s Executive MBA is designed for focused, driven leaders who are positioned to move into senior executive and C-suite…
SELENA+ ADOPTED AS FIRST MEDICAL AI IN BRUNEI DARUSSALAM
24 Apr 2024 – It is estimated that Brunei Darussalam has a diabetes prevalence of about 13% and evidence reveals that 1 in 3 diabetic patients develops diabetic retinopathy, which left untreated can lead to blindness. This morning, Jerudong Park Medical Centre (JPMC) launched the SELENA+ Artificial Intelligence Diabetic Retinopathy Screening Service – the first AI eye screening service in…
SELENA+ IN ACTION DURING DIABETES MALAYSIA AGM
21 Apr 2024 – Nova MSC provided eye screening for the members of Diabetes Malaysia (Penang Branch) during their Annual General Meeting (AGM) in Penang Adventist Hospital (PAH). With the help from Diabetes Malaysia, we have managed to screen more than 20 of their members for eye diseases using SELENA+ an advanced diagnostic tool to autonomously detect diabetic retinopathy, glaucoma…
EYRIS PARTICIPATES IN DIABETIC RETINOPATHY SCREENING INITIATIVE IN MONGOLIA
15 Apr 2024 – EyRIS is thrilled to announce our partnership with iCare in support of Sight For All’s mission to combat preventable blindness in Mongolia. We are humbled to be invited to participate in this meaningful community outreach project by way of contributing our flagship product SELENA+, an advanced diagnostic tool to autonomously detect diabetic retinopathy, glaucoma and Aged-Related…
EyRIS FOUNDER NAMED ON ASIA WOMEN TECH LEADERS (AWTL) AWARD LIST
28 Mar 2024 – Professor Wynne Hsu, leading the Institute of Data Science at the National University of Singapore, is a key figure in data science and AI in healthcare, focusing on developing new machine learning techniques for real-world applications. Her significant contributions include SELENA+, a deep learning-based solution for the screening of eye disease (diabetic retinopathy, glaucoma, cataract) from…
KASIH IBU GROUP TO RUN CENTRALISED VESALIUS FOR ALL HOSPITALS
20 Mar 2024 – Since 1987, the Kasih Ibu Hospital (KIH) group has gained a strong reputation for providing quality and affordable medical care in a modern setting aided by advanced diagnostic equipment. To-date, the group has expanded to four different sites, making it the hospital with the widest reach in Bali. In 2018, KIH chose to implement VESALIUS hospital…
ISLAND HOSPITAL ROLLS-OUT VESALIUS MOBILE APP FOR PATIENTS
15 Feb 2024 – Established in 1996, Island Hospital (IH) in Penang has grown to become a 600-bed internationally accredited healthcare facility that provides quality care to both local and international communities. With a total 200,000 health traveller visits from more than 70 countries in 2023, IH stands at the forefront of medical tourism in Malaysia. As a result, IH…
PLINY & EYRIS JOIN HANDS TO ENSURE INTEROPERABILITY
2 Feb 2024 – We are thrilled to unveil a groundbreaking partnership: EyRIS and Pliny are joining forces through a Memorandum of Understanding (MOU), paving the way for a strategic collaboration that promises to revolutionize the delivery of eye care. Through seamless integration with ophthalmic modalities, Pliny provides centralized storage and a unified view of all patient diagnostic scans in…
VESALIUS V21 CERTIFIED FOR SATUSEHAT BY MOH INDONESIA
30 Jan 2024 – Announced in 2022, SATUSEHAT is Ministry of Health Indonesia’s initiative to build a digital eco-system to facilitate data exchange and service efficiency for care providers and government through the seamless integration of healthcare facilities and IT systems they are running. SATUSEHAT also serves a medium for the public to access their own Electronic Medical Record (EMR)…
EYRIS CONGRATULATES FOUNDER ON APPOINTMENT TO NEJM AI EDITORIAL BOARD
Jan 2024 – EyRIS extends our heartiest congratulations to our founder Prof. Tien Yin Wong for his recent appointment to the NEJM AI Editorial Board. NEJM AI, a new monthly journal from NEJM Group, is the first publication to engage both clinical and technology innovators in applying the rigorous research and publishing standards of the New England Journal of Medicine…
NOVA MSC SECURES RM35.4 MILLION AUTOMATION CONTRACT
26 Jan 2024 – Nova MSC Berhad’s (“Nova MSC” or “the Company”), a leading provider of innovative technology solutions, is excited to announce that its wholly-owned subsidiary, novaCITYNETS Pte Ltd (“NCN”), has been awarded a significant RM35.4 million contract by Sys-Mac Automation Engineering Pte Ltd (“Sys-Mac”) in Singapore. Under this contract, NCN will be responsible for the supply, delivery, installation,…
EYRIS ANNOUNCES COLLABORATION WITH ICARE
23 Jan 2024 – We are thrilled to announce the successful conclusion of our collaborative agreement with iCare, marking a significant milestone in the world of eye care. The partnership will result in both companies working together to seamlessly integrate SELENA+ our AI for retinal diseases with iCare’s proprietary platform, ILLUME. ILLUME, developed by iCare, is a cutting-edge platform meticulously…